Side effects of albuterol
Pro Research Analysisby 
Searched over 200M research papers
Common Side Effects of Albuterol: Cardiovascular and Metabolic Effects
Albuterol, a beta2-adrenergic agonist, is known to cause several dose-related side effects, especially when administered in higher doses or via systemic routes. The most frequently reported cardiovascular side effects include increased heart rate (tachycardia), elevated systolic blood pressure, and decreased diastolic blood pressure. These effects can occur rapidly, sometimes within five minutes of inhalation, and typically peak within 30 minutes after administration. Albuterol also causes metabolic changes such as increased serum glucose and insulin levels, and a decrease in serum potassium, phosphate, calcium, and magnesium concentrations. These side effects are more pronounced with higher or systemic doses, but can still occur with inhaled forms, especially at increased doses 1235.
Neuromuscular and Other Side Effects: Tremor and Hyperactivity
Skeletal muscle tremor is a well-documented side effect of albuterol, particularly at higher doses. In children, other side effects such as hyperactivity and vomiting have also been observed, but these are generally not significantly different between high and low dose regimens. The incidence of these side effects does not appear to correlate directly with serum albuterol levels 26.
Respiratory and Perioperative Effects: Cough, Wheezing, and Airway Events
Albuterol is effective in reducing the incidence of wheezing and recurrent cough, especially in perioperative settings for patients with chronic obstructive pulmonary disease (COPD) or children undergoing tonsillectomy. In these contexts, albuterol premedication has been shown to significantly lower the rates of perioperative respiratory adverse events such as bronchospasm, laryngospasm, airway obstruction, desaturation, and coughing, with no significant side effects detected in the treated groups 47.
Dose-Related Side Effects: High vs. Low Dose and Route of Administration
Higher doses of inhaled albuterol provide greater bronchodilation but are associated with a higher risk of side effects, including increased heart rate, tremor, and supraventricular ectopic beats, as well as a dose-related fall in oxygen saturation. However, the frequency of more serious arrhythmias does not appear to increase with higher doses. Parenteral (injected) albuterol is more likely to cause significant metabolic disturbances, particularly hypokalemia (low potassium), which may have important clinical implications 356.
Comparison with Other Beta-Agonists and Administration Methods
Compared to other beta-agonists like isoetharine, albuterol tends to have fewer side effects while providing similar efficacy in relieving bronchospasm. The method of administration (continuous vs. intermittent nebulization) does not significantly alter the side effect profile at standard doses, and both methods are considered safe in acute asthma management 810.
Conclusion
Albuterol is generally safe and effective for the treatment of asthma and other respiratory conditions, but it can cause side effects such as increased heart rate, changes in blood pressure, tremor, metabolic disturbances (notably hypokalemia and increased glucose), and, less commonly, hyperactivity or vomiting in children. These side effects are more likely with higher or systemic doses. Inhaled albuterol, especially at standard doses, is associated with minimal side effects and is well-tolerated in both adults and children.
Sources and full results
Most relevant research papers on this topic